COLANTUONO, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 1.306
EU - Europa 476
AS - Asia 235
AF - Africa 7
SA - Sud America 4
Totale 2.028
Nazione #
US - Stati Uniti d'America 1.292
IT - Italia 158
SE - Svezia 140
SG - Singapore 103
IN - India 75
CN - Cina 47
UA - Ucraina 31
DE - Germania 28
FI - Finlandia 26
BG - Bulgaria 25
GB - Regno Unito 22
CA - Canada 12
RO - Romania 10
FR - Francia 7
IE - Irlanda 6
RU - Federazione Russa 6
BE - Belgio 5
CZ - Repubblica Ceca 5
ID - Indonesia 5
TG - Togo 5
LU - Lussemburgo 4
AR - Argentina 2
CL - Cile 2
MX - Messico 2
NL - Olanda 2
AZ - Azerbaigian 1
BJ - Benin 1
CH - Svizzera 1
IR - Iran 1
JP - Giappone 1
TR - Turchia 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 2.028
Città #
Chandler 173
Fairfield 158
Ashburn 122
Woodbridge 86
Singapore 79
Seattle 71
Wilmington 68
Cambridge 66
Rome 62
Houston 60
Princeton 41
Ann Arbor 40
Beijing 30
Dearborn 29
Sofia 25
Plano 24
Boston 22
San Paolo di Civitate 20
Andover 18
Lawrence 15
San Diego 14
Millbury 11
Santa Clara 11
Southend 11
Jacksonville 8
Munich 8
San Mateo 7
Toronto 7
Bremen 6
Cagliari 6
Dublin 6
New York 6
Brno 5
Brussels 5
Helsinki 5
Jakarta 5
Lomé 5
Nanjing 5
Norwalk 5
Dallas 4
Hefei 4
Milan 4
North Vancouver 4
Bühl 3
Des Moines 3
Falls Church 3
Fuzhou 3
Mannheim 3
Pune 3
Boardman 2
Carloforte 2
Federal 2
Frankfurt am Main 2
Indiana 2
Lissone 2
Los Angeles 2
Piacenza 2
Pompei 2
Viterbo 2
Aci Catena 1
Agropoli 1
Albano Laziale 1
Auburn Hills 1
Aytre 1
Bari 1
Bern 1
Castellammare Di Stabia 1
Changsha 1
Chignolo d'Isola 1
Ciciliano 1
Fasano 1
Ferentino 1
Fremont 1
Gatchina 1
Gelsenkirchen 1
Guangzhou 1
Hackney 1
Hanoi 1
Harbin 1
Hounslow 1
Hyderabad 1
Incisa 1
Istanbul 1
London 1
Lviv 1
Mexico City 1
Muizenberg 1
Ottawa 1
Paris 1
Parma 1
Phoenix 1
Provo 1
Reims 1
Roseto Degli Abruzzi 1
Santiago Metropolitan 1
Tokyo 1
Trumbull 1
Totale 1.437
Nome #
A case of tension-type headache in fibromyalgia. 110
Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review 99
Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia 95
Efficacy and safety of long-term treatment with low-dose rituximab for relapsing mixed cryoglobulinemia vasculitis 89
Reversion of anergy signatures in clonal CD21low B cells of mixed cryoglobulinemia after clearance of HCV viremia. 86
The case for cost-effectively treating cryoglobulinemic vasculitis with interferon-free anti-hepatitis C virus therapy. 85
Un caso di cefalea tensiva da fibromialgia 84
Clinical, neurophysiological, and skin biopsy findings in peripheral neuropathy associated with hepatitis C virus-related cryoglobulinemia 81
Acquired cow's milk sensitization after liver transplant in an adult: "clinical implications" and future strategies 79
CD21low B cells in systemic sclerosis: a possible marker of vascular complications 77
A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection 74
Health related quality of life in common variable immunodeficiency 72
Long-lasting persistence of large B-cell clones in hepatitis C virus-cured patients with complete response of mixed cryoglobulinaemia vasculitis. 72
Cirrosi biliare primitiva 66
Early benralizumab for eosinophilic myocarditis in eosinophilic granulomatosis with polyangiitis 62
Late relapses of hepatitis C virus-cured mixed cryoglobulinaemia associated with infection or cancer 61
CD21 low B cells are predictive markers of new digital ulcers in systemic sclerosis 57
A curious case of type 2 APS 54
Clinico-immunologic outcomes of HCV-cured cryoglobulinemia: lower relapse rate with interferon-based than interferon-free therapy 53
A stereotyped light chain may shape virus-specific B-cell receptors in HCV-dependent lymphoproliferative disorders 52
A case of headache in a patient with SLE 46
A singular case of hemolytic anemia. 44
A misleading macroglossia 43
Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia 42
Meningoencefalite? no, sindrome di Moskowitz. 40
Un caso di Les con ipertransaminasemia come caratteristica principale. 40
Cryoglobulins: putative effectors of adaptive immune response 39
Safety and effectiveness of biosimilar of Rituximab CT‐P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar) 38
Posterior reversibile encephalopathy syndrome 36
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 34
Rheumatoid factor-producing CD21low anergic clonal B-cells in essential mixed cryoglobulinaemia: a model for autoantigen-driven pathogenesis of infectious and non-infectious cryoglobulinaemias 33
Immunobiology of essential mixed cryoglobulinemia 32
Necrosis of the toes and hemolytic anemia. What is the best management? 32
Safety of an Accelerated Build-up Phase With Pollen Allergoids: A Retrospective Study 31
Adherence to Allergen Subcutaneous Immunotherapy is Increased by a Shortened Build-Up Phase: A Retrospective Study 30
Dual stimulation by autoantigen and CpG fosters the proliferation of exhausted rheumatoid factor-specific CD21low B cells in hepatitis C virus-cured mixed cryoglobulinemia 29
Mutational and immunogenetic landscape of HCV-associated B-cell lymphoproliferative disorders 28
The Marginal Zone B Cells Clonally Expanded in Hepatitis C-Related Mixed Cryoglobulinemia Display the Functional and Molecular Signatures of Anergy Induced by Continual B Cell Receptor Signaling 21
Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: a case report 17
Totale 2.163
Categoria #
all - tutte 6.299
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.299


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020284 0 0 0 0 29 51 41 35 37 36 29 26
2020/2021229 20 28 8 6 11 19 4 19 34 56 18 6
2021/2022414 42 18 34 15 53 19 6 38 26 33 62 68
2022/2023513 98 107 34 62 49 52 16 27 45 0 17 6
2023/2024228 12 33 5 27 16 61 6 14 0 21 16 17
2024/2025139 22 67 24 26 0 0 0 0 0 0 0 0
Totale 2.163